Clinical trials: Severe Emphysema, open to volunteers
Emphysema, COPD
Zephyr Valve Japan Post-Marketing Surveillance
This is a multicenter, prospective, observational surveillance enrolling 140 consecutive patients with severe emphysema who are candidates for bronchoscopic lung volume reduction using Zephyr Endobronchial Valve at up to 20…
- Conditions
- Emphysema, COPD, Severe Emphysema
- Trial name
- NCT06332885
- Testing
- Zephyr Endobronchial Valve
- Where
- 17 sites in Japan
- Volunteers
- 140 people
- Sponsor
- Pulmonx Corporation
Severe Emphysema
A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
To compare the efficacy and safety of subsegmental treatment and segmental treatment with InterVapor in patients with severe emphysema
- Trial name
- BTVA (NCT06152107)
- Testing
- BTVA treatment plus optimal medical therapy (GOLD guidelines)
- Where
- 9 sites in China
- Volunteers
- 100 people
- Sponsor
- Shanghai Chest Hospital